Elevated circulating interleukin-17 levels in systemic sclerosis: a meta-analysis [0.03%]
系统性硬化症循环中IL-17水平升高的meta分析研究
Young Ho Lee,Gwan Gyu Song
Young Ho Lee
Objective: The aim of this meta-analysis was to evaluate the association between circulating interleukin-17 (IL-17) levels and systemic sclerosis (SSc). M...
Risk of cardiovascular disease associated with use of tumor necrosis factor inhibitors in ankylosing spondylitis [0.03%]
肿瘤坏死因子抑制剂在强直性脊柱炎患者中的使用与心血管疾病风险相关性研究
Ji-Won Kim,Jun Sik Yoon,Sojeong Park et al.
Ji-Won Kim et al.
Objective: To examine the risk of cardiovascular disease (CVD) associated with use of tumor necrosis factor inhibitors (TNFi) in patients with ankylosing spondylitis (AS). ...
Genetic and epigenetic insights into systemic lupus erythematosus: linking long non-coding RNA growth arrest-specific transcript 5 and interferon signature [0.03%]
系统性红斑狼疮的遗传学和表观遗传学研究进展：长链非编码RNA生长阻滞特异性转录物5与I型干扰素信号通路关系的探索
Gehad Gamal Maghraby,Manal Abdel-Moneim El-Menyawi,Hanan A Abdel Rehiem et al.
Gehad Gamal Maghraby et al.
Objective: Interferon (IFN) signaling, and excessive apoptosis have a well-established role in systemic lupus erythematosus (SLE) pathogenesis. Long non-coding RNA (lncRNA) growth arrest-specific transcript 5 (GAS5) has b...
Cytomegalovirus retinitis during upadacitinib monotherapy for rheumatoid arthritis: a case report [0.03%]
乌帕替尼单药治疗类风湿关节炎期间出现巨细胞病毒性视网膜炎一例报告
Sang Jun Park,Yun Jong Lee
Sang Jun Park
Janus kinase inhibitors (JAKis) are associated with increased risk of Varicella-Zoster Virus reactivation, particularly in Asian populations. While reactivation of cytomegalovirus (CMV) is very rare in rheumatoid arthritis (RA) patients on ...
Review of literature: posterior reversible encephalopathy syndrome in systemic lupus erythematosus [0.03%]
系统性红斑狼疮后可逆性脑病文献复习
Farah Jaafar Mahdi
Farah Jaafar Mahdi
Posterior reversible encephalopathy syndrome (PRES) is a neuroradiological disorder primarily affecting the posterior circulation of the brain. It manifests with a spectrum of symptoms, typically accompanied by hypertension, headache, seizu...
Validity of a claim-based algorithm for classifying disease activity levels using Systemic Lupus Erythematosus Disease Activity Index 2000 in Korean patients with systemic lupus erythematosus [0.03%]
基于理赔资料的系统性红斑狼疮疾病活动程度分类算法在韩国系统性红斑狼疮患者中的验证研究：使用SLEDAI-2K标准
Yoon-Kyoung Sung,Ha-Rim Park,Eunwoo Nam et al.
Yoon-Kyoung Sung et al.
Objective: To validate algorithms for classifying disease activity in patients with systemic lupus erythematosus (SLE) using Korean claims data. Methods: ...
Association between sarcopenia and physical activity in individuals with spondyloarthritis [0.03%]
肌少症与轴肿关节炎个体身体活动之间的联系
Bruna Oliveira Corrêa do Amaral,Christianne de Faria Coelho-Ravagnani,Ana Beatriz Silva de Vasconcelos et al.
Bruna Oliveira Corrêa do Amaral et al.
Objective: To assess the association between sarcopenia and physical activity in individuals with spondyloarthritis (SpA). Methods: Phy...
Wan Kee Hong,Joong Mo Ahn,Hyun Sik Gong
Wan Kee Hong
Rheumatoid arthritis (RA) is a chronic inflammatory condition that significantly impacts multiple joints, including the elbow, crucial for daily activities. Despite advancements in medical treatments like disease-modifying antirheumatic dru...
Rheumatoid factor and anti-cyclic citrullinated peptide antibody levels decline in rheumatoid arthritis patients treated with Janus kinase inhibitors or biological disease-modifying anti-rheumatic drugs [0.03%]
Janus激酶抑制剂或生物改善病情抗风湿药治疗可降低类风湿关节炎患者类风湿因子和抗环瓜氨酸肽抗体水平
Bo Young Kim,Ji-Won Kim,Hwajeong Lee et al.
Bo Young Kim et al.
Objective: We aimed to investigate the rate of decline in serum anti-cyclic citrullinated peptide antibody (ACPA) and rheumatoid factor (RF) levels in rheumatoid arthritis (RA) patients treated with Janus kinase inhibitor...